Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Injectable Medicines Through World-Class Capabilities - Dr. Reddy's Laboratories

Many of today's leading drugs are directly injected into the patient's body, which is why the global injectable drug delivery market is anticipated to grow at a rate of 8.67 percent through 2027. This growth is reflective of Dr. Reddy's injectable portfolio for medical specialties. The team at Dr. Reddy's has made a concerted effort to ensure that their injectable delivery system exceeds patient need and improves the injectable experience.

Dr. Reddy's Laboratories have honed its capabilities in the injectable and inhalation space through world-class capabilities and best-in-class teams. Their work has resulted in a strong track record in developing, marketing, and distributing generic injectables. These credentials and operations contribute to the accessibility and affordability of medications.


Dr. Reddy's most recently launched injectable is Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules, a therapeutic equivalent generic version of DDAVP (desmopressin acetate) Injection 4 mcg/mL, approved by the FDA. This product is a strong addition to the injectable offerings in the U.S. market and reflects a commitment to act with speed to find innovative solutions and accelerate access to much-needed medicines.

Today's Posts


SPOTLIGHTS are brief introductions to companies, products, product features,
and services that could potentially benefit the pharmacy operations of RXinsider's readership.



To suggest a subject to be profiled in a SPOTLIGHT, please contact 
your RXinsider Account Manager or RXinsider's Marketing and Operations Manager, Samantha Roy.

This post is related to:

Generics, Brand Name, Biotech